First-Line Lenvatinib in Child-Pugh B Patients With HCC Unsuitable for Curative Treatment
Clinical trial NCT07297654 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07297654
- Sponsor
- National Cancer Center, Korea
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2028-05-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.